Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
SPRC
#6742
SciSparc Ltd. Ordinary Shares
0.5
6
-3.45%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-3.45%
Monatliche Änderung
-36.36%
6 month change
-88.26%
Jahresänderung
+51.35%
Vorheriger Schlusskurs
0.5
8
Open
0.5
6
Bid
Ask
Low
0.5
6
High
0.5
6
Volumen
1
Märkte
Aktien
Gesundheitswesen
SPRC
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
265.84 K
5 662.53
12.45 K
33.65 K
515.63 K
567.4 K
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
1.38
0.58
0.24
0.53
0.72
—
Return on equity %
2.47
0.71
0.4
0.61
0.84
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
76.1
76.28
38.74
—
Operating margin %
—
—
615.22
236.71
560.18
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
192.43
204.34
572.13
—
Liquidity ratios
Quick ratio
—
—
0.92
3.63
5.28
—
Current ratio
2.25
5.59
1.09
4.1
5.36
—
Inventory turnover
—
—
0.48
0.97
1.87
—
Asset turnover
—
—
0.13
0.26
0.12
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
Nachrichten
SciSparc-Tochter erhält US-Patent für Cannabinoid-Technologie zur Verstärkung von Antibiotika
SciSparc subsidiary receives U.S. patent for antibiotic-enhancing cannabinoid technology
SciSparc steigt mit Übernahme von Medizintechnik-Portfolio in den Markt für Reflux-Behandlung ein
SciSparc acquires MUSE system IP portfolio to enter GERD device market
SciSparc übernimmt Patente für endoskopisches System MUSE von Xylo
SciSparc to acquire MUSE endoscopic system patents from Xylo
SciSparc Moves Into Endoscopy With Strategic Patent Deal - SciSparc (NASDAQ:SPRC)
SciSparc erfüllt NASDAQ-Eigenkapitalanforderung nicht
SciSparc receives Nasdaq non-compliance notice for stockholders’ equity
SciSparc-Tochter NeuroThera erhält Patent in Israel für Opioid-Technologie
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech
IM Cannabis ernennt Asi Levi zum neuen CFO